Latest Breaking News On - Pascal touchon - Page 4 : comparemela.com

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data in The Lancet Oncology

01.02.2024 - Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, and Pierre . Seite 1

United statesPascal touchonAmerican society of hematologyAtara biotherapeutics incEuropean unionPierre fabre laboratoriesPierre fabreChief executive officerLancet oncologyAtara biotherapeutics chartTara biotherapeutics kursTara biotherapeutics aktie

Atara Biotherapeutics, Inc : Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data in The Lancet Oncology

Atara Biotherapeutics, Inc : Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data in The Lancet Oncology
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesLaurence marchalPierre fabre laboratoriePierre fabreAlex chapmanStefan klotterPascal touchonEuropean unionAmerican society of hematologyExchange commissionCorporate communications investor relationsSecurities exchangePierre fabre foundationAtara biotherapeutics incFirst phaseAllogeneict cell

ATARA Biotherapeutics (ATRA) and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data

ATARA Biotherapeutics (ATRA) and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDana farber cancer instituteSusan prockopPrix galienPascal touchonAtara biotherapeutics incAmerican society of hematologyAccess programEuropean unionDrug administrationAmerican society of clinical oncologyEuropean commissionPierre fabre laboratoriesChief executive officerLancet oncologyExpanded access program

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMidi pyréesStefan klotterAlex chapmanPierre fabre laboratoriePascal touchonLaurence marchalPierre fabreAtara biotherapeutics incAmerican society of hematologyPierre fabre foundationEuropean unionCorporate communications investor relationsSecurities exchangeExchange commissionPrnewswire atara biotherapeutics inc

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMidi pyréesDana farber cancer instituteLaurence marchalPierre fabre laboratoriePierre fabrePascal touchonPrix galienAlex chapmanSusan prockopAmerican society of clinical oncologyDrug administrationPierre fabre foundationAtara biotherapeutics incCorporate communications investor relationsAmerican society of hematology